Microbiome & Mitochondrial Intervention Research for Parkinson's Disease

Research into microbiome & mitochondrial intervention research approaches for Parkinson's Disease. AI-powered analysis of mechanisms, evidence, and clinical status.

About Microbiome & Mitochondrial Intervention Research

Research into gut-brain axis modulation, microbiome composition optimization, mitochondrial biogenesis, and metabolic rescue strategies. No FMT — focused on targeted prebiotics, postbiotics, and mitochondrial activators.

About Parkinson's Disease

2026 Parkinson's treatment advances: alpha-synuclein targeting, LRRK2 gene therapy, nicotinamide riboside trials. AI-analyzed with safety scores.

Standard of Care: Levodopa/Carbidopa, dopamine agonists, MAO-B inhibitors, deep brain stimulation — primarily dopamine replacement and symptom control.